CD8A and glioma: However, CD8+ TILs that have been detected in glioma and colon cancer showed increased activation and cytotoxicity, as indicated by elevated levels of interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), and IL-2 protein [20] or RNA synthesis [24].